Jeffrey A Tornheim

7PUBLICATIONS
29CO-AUTHORS
Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)ChiropracticCognitive and computational psychology not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Analytical Method Development and Validation for Clofazimine in Human Plasma and Application of LC-MS/MS Based Methods for Clofazimine and Bedaquiline in Indian MDR-TB Patients Stratified by HIV Coinfection.

|Sep 02, 2025
Evaluation of cycloserine dose regimens in an Indian cohort with multidrug-resistant tuberculosis: a population pharmacokinetic analysis.

Juan Eduardo Resendiz-Galvan, Prerna R Arora, Rohan V Lokhande

|Feb 13, 2023
Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries.

Kathrin Zürcher, Samyra R Cox, Marie Ballif

|Jan 30, 2023
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.

Annukka A R Antar, Tong Yu, Zoe O Demko

|Jan 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India.

Jeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora

|Dec 24, 2021
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis.

Jeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora

Pageof 2

Frequent Collaborators

2 joint publications

Amita Gupta

2 joint publications

Tester F Ashavaid

2 joint publications

Prerna R Arora

1 joint publications

Lancelot M Pinto